RBBP4 expression is higher in triple-negative and HER2-positive tumours in comparison with luminal A and luminal B tumours, correlates positively with HDAC1 expression, and correlates negatively with ER and PR expression. The gene discussed is RBBP4; the disease is neoplasm.